Emergence of lymphomatoid papulosis during treatment with brentuximab vedotin

Int J Dermatol. 2020 Sep;59(9):e332-e334. doi: 10.1111/ijd.15009. Epub 2020 Jun 23.

Authors

Nazish Mansoor¹, Laura McKenna², Oonagh Molloy¹, Elizabeth Smyth³, Richard Flavin⁴, Cliona Ryan², John Quinn^{3

5}, Muireann Roche¹

Affiliations

¹ Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
² Department of Histopathology, Beaumont Hospital, Dublin, Ireland.
³ Department of Haematology, Beaumont Hospital, Dublin, Ireland.
⁴ Department of Histopathology, St James' Hospital, Dublin, Ireland.
⁵ School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.

PMID: 32578212
DOI: 10.1111/ijd.15009

No abstract available

Publication types

Letter

MeSH terms

Brentuximab Vedotin
Humans
Lymphomatoid Papulosis* / chemically induced
Skin Neoplasms* / chemically induced
Skin Neoplasms* / drug therapy

Substances

Brentuximab Vedotin